At the time of writing, Edwards Lifesciences Corp [EW] stock is trading at $76.19, up 0.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EW shares have gain 8.30% over the last week, with a monthly amount glided 8.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on January 30, 2025, when Stifel upgraded its rating to a Buy and also boosted its price target to $90 from $75. Previously, Wolfe Research downgraded its rating to Underperform on January 16, 2025, and kept the price target unchanged to $60. On December 16, 2024, upgrade upgraded it’s rating to Buy. Jefferies downgraded its rating to a Hold and reduced its price target to $70 on September 18, 2024. Daiwa Securities upgraded its rating to Outperform for this stock on July 31, 2024. In a note dated July 29, 2024, Wolfe Research upgraded an Peer Perform rating on this stock.
For the past year, the stock price of Edwards Lifesciences Corp fluctuated between $58.93 and $96.12. Currently, Wall Street analysts expect the stock to reach $76.58 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $76.19 at the most recent close of the market. An investor can expect a potential return of 0.51% based on the average EW price forecast.
Analyzing the EW fundamentals
According to Edwards Lifesciences Corp [NYSE:EW], the company’s sales were 5.72B for trailing twelve months, which represents an -9.67% plunge. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.71%. To continue investigating profitability, this company’s Return on Assets is posted at 0.32, Equity is 0.54 and Total Capital is 0.14. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 75.71 points at the first support level, and at 75.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 76.70, and for the 2nd resistance point, it is at 77.21.
Ratios To Look Out For
It is important to note that Edwards Lifesciences Corp [NYSE:EW] has a current ratio of 3.46. In addition, the Quick Ratio stands at 2.89 and the Cash Ratio stands at 1.89. Considering the valuation of this stock, the price to sales ratio is 7.85, the price to book ratio is 4.71 and price to earnings (TTM) ratio is 10.93.
Transactions by insiders
Recent insider trading involved LORANGER STEVEN R, Director, that happened on Feb 14 ’25 when 5739.0 shares were sold. Director, LORANGER STEVEN R completed a deal on Feb 14 ’25 to buy 5739.0 shares. Meanwhile, CVP, Chief Financial Officer Ullem Scott B. sold 11250.0 shares on Feb 13 ’25.
